- Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach
Nelson C. Soares et al, 2022, Journal of Proteomics CrossRef - Crosstalk between Ca2+ Signaling and Cancer Stemness: The Link to Cisplatin Resistance
Sana Kouba et al, 2022, IJMS CrossRef - Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings
Giovanni Tossetta, 2022, IJMS CrossRef - Role of RAS signaling in ovarian cancer
Lubna Therachiyil et al, 2022, F1000Res CrossRef - Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer
Wenwen Zhang et al, 2022, Front. Genet. CrossRef - A trans-Pt(ii) hedgehog pathway inhibitor complex with cytotoxicity towards breast cancer stem cells and triple negative breast cancer cells
Aisling L. Ryan et al, 2022, Dalton Trans. CrossRef - New progress of glutamine metabolism in the occurrence, development, and treatment of ovarian cancer from mechanism to clinic
Xiaojing Yang et al, 2022, Front. Oncol. CrossRef - Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
Elisa Pardella et al, 2022, Cells CrossRef - Targeting the NRF2/KEAP1 pathway in cervical and endometrial cancers
Giovanni Tossetta et al, 2023, European Journal of Pharmacology CrossRef - Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis
Qingsong Zeng et al, 2023, Cancer Medicine CrossRef - Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Ebrahim H. Maleki et al, 2023, Genes & Diseases CrossRef - Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines
Marie-Christin Barth et al, 2023, IJMS CrossRef - Sustained delivery of PARP inhibitor Talazoparib for the treatment of BRCA-deficient ovarian cancer
Shicheng Yang et al, 2023, Front. Oncol. CrossRef - Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
Min Yin et al, 2023, BMC Women's Health CrossRef - A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis
Philipp König et al, 2023, Cancer Chemother Pharmacol CrossRef - Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisplatin
Li Zhu et al, 2023, Journal of Chemotherapy CrossRef - Mechanisms of autophagy and endoplasmic reticulum stress in the reversal of platinum resistance of epithelial ovarian cancer cells by naringin
Jun Zhu et al, 2023, Mol Biol Rep CrossRef - Targeting the stimulator of interferon genes (STING) in breast cancer
Ma Ying-Rui et al, 2023, Front. Pharmacol. CrossRef - Scutellaria baicalensis Georgi and Their Natural Flavonoid Compounds in the Treatment of Ovarian Cancer: A Review
Jiaying Cai et al, 2023, Molecules CrossRef - Potentiation of Cisplatin Cytotoxicity in Resistant Ovarian Cancer SKOV3/Cisplatin Cells by Quercetin Pre-Treatment
Aseel Ali Hasan et al, 2023, IJMS CrossRef - Single-cell RNA sequencing reveals a pro-metastatic subpopulation and the driver transcription factor NFE2L1 in ovarian cancer cells
Junseong Park et al, 2023, Genes Genom CrossRef - Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer
Gerrit Hugendieck et al, 2023, J of Extracellular Vesicle CrossRef - Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers
Tetiana Korzun et al, 2023, Small CrossRef - Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer
Chenxi Wang et al, 2023, Expert Opinion on Therapeutic Targets CrossRef - Enzymatically crosslinked magnetic starch-grafted poly(tannic acid) hydrogel for “smart” cancer treatment: An in vitro chemo/hyperthermia therapy study
Morteza Eskandani et al, 2023, International Journal of Biological Macromolecules CrossRef - Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells
Michal Kielbik et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef - Nano-curcumin formulations for targeted therapy of colorectal cancer
Hossein Shahdadi Sardou et al, 2023, Journal of Drug Delivery Science and Technology CrossRef - Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells
Farah H. Abdalbari et al, 2023, Cancers CrossRef - Meta‐analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer
Somayeh Hashemi Sheikhshabani et al, 2023, Cancer Reports CrossRef - PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway
Fang Zheng et al, 2023, J Exp Clin Cancer Res CrossRef - Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Sevgi Ayhan et al, 2023, J Ovarian Res CrossRef - CT radiomics prediction of CXCL9 expression and survival in ovarian cancer
Rui Gu et al, 2023, J Ovarian Res CrossRef - Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer
Jiao Wang et al, 2023, J Ovarian Res CrossRef - CD39+MDSC Facilitates Cisplatin Resistance of Ovarian Cancer Cells by
Affecting Adenosine Synthesis
Jiong Ma et al, 2023, CPD CrossRef - The microbiome and ovarian cancer: insights, implications, and therapeutic opportunities
Yogita Mehra et al, 2023, J Cancer Metastasis Treat CrossRef - null
Andrea Cuschieri et al, 2023 CrossRef - Beyond Sterilization: A Comprehensive Review on the Safety and Efficacy of Opportunistic Salpingectomy as a Preventative Strategy for Ovarian Cancer
Tahereh Zadabedini Masouleh et al, 2023, Current Oncology CrossRef - The impact of PARP inhibitors in the whole scenario of Ovarian Cancer management: a Systematic Review and Network Meta-Analysis
Nicoletta Staropoli et al, 2023, Critical Reviews in Oncology/Hematology CrossRef - Deep learning enhanced the diagnostic merit of serum glycome for multiple cancers
Haobo Zhang et al, 2024, iScience CrossRef - A benzimidazolium salt induces apoptosis and arrests cells at sub-G1 phase in epithelial ovarian cancer cells
Sakine Akar et al, 2024, Mol Biol Rep CrossRef - Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma
Xiaojiang Wang et al, 2024, Intl Journal of Cancer CrossRef - Methylene Blue Metabolic Therapy Restrains In Vivo Ovarian Tumor Growth
Jorgelindo da Veiga Moreira et al, 2024, Cancers CrossRef - Combined radiomics-clinical model to predict platinum-sensitivity in advanced high-grade serous ovarian carcinoma using multimodal MRI
Inye Na et al, 2024, Front. Oncol. CrossRef - ITGB2 fosters the cancerous characteristics of ovarian cancer cells through its role in mitochondrial glycolysis transformation
Li Guo-Wei et al, 2024, Aging CrossRef - Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target
Wei Li et al, 2024, BMC Genomics CrossRef - null
Katie E. Allen et al, 2023 CrossRef - HMGB1 enhances the migratory and invasive abilities of A2780/DDP cells by facilitating epithelial to mesenchymal transition via GSK‑3β
Jinhua Wang et al, 2024, Exp Ther Med CrossRef - Hsa_circ_0000585 promotes chemoresistance to cis-platin in epithelial cells of ovarian cancer by modulating autophagy
Pei Du et al, 2023, Biochemical and Biophysical Research Communications CrossRef - Apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) promotes stress granule formation via YBX1 phosphorylation in ovarian cancer
Shuyu Mao et al, 2024, Cell. Mol. Life Sci. CrossRef - Refining molecular subtypes and risk stratification of ovarian cancer through multi‐omics consensus portfolio and machine learning
Jing Zhang et al, 2024, Environmental Toxicology CrossRef - Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer
Ruyue Li et al, 2024, World J Surg Onc CrossRef - A Stem-like Patient-Derived Ovarian Cancer Model of Platinum Resistance Reveals Dissociation of Stemness and Resistance
Tise Suzuki et al, 2024, IJMS CrossRef - Photo-responsive doxorubicin delivery: Nanogel systems based on azobenzene and host-guest interactions enhanced by squeezing action
Samaneh Yousefi Adlsadabad et al, 2024, Polymer CrossRef - Exploring the Antiproliferative and Modulatory Effects of 1-Methoxyisobrassinin on Ovarian Cancer Cells: Insights into Cell Cycle Regulation, Apoptosis, Autophagy, and Its Interactions with NAC
Martina Zigová et al, 2024, Molecules CrossRef - Therapeutic strategies targeting folate receptor α for ovarian cancer
Jia Mai et al, 2023, Front. Immunol. CrossRef